Cite
HARVARD Citation
Grevel, J. et al. (2019). Exposure–Response Modeling and Simulation of Progression‐Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer. Clinical and translational science. 12 (5), pp. 459-469. [Online].